Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/BCP.12795PMID 26446447PMCID PMC4833169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models

  2017cited by this paper
• Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review

  2017cited by this paper
• Update on Chemotherapy-Induced Peripheral Neuropathy

  2017cited by this paper
• Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study

  2017cited by this paper
• Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.

  2016cited by this paper
• Potential drug interaction between paclitaxel and clopidogrel.

  2016cited by this paper
• CYP2C19*17 increases clopidogrel‐mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel

  2014cited by this paper
• Glucuronidation Converts Clopidogrel to a Strong Time‐Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions

  2014cited by this paper
• Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer.

  2012cited by this paper
• Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer

  2011cited by this paper
• Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer

  2005cited by this paper
• Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

  1994cited by this paper
• Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.

  1994cited by this paper

• Dysregulated BARD1 Contributes to Paclitaxel Resistance in Ovarian Cancer via Up-regulating CYP2C8.

  2025cites this paper
• Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in Humans

  2024cites this paper
• Elevated Platelet Aggregation in Patients with Ovarian Cancer: More than Just Increased Platelet Count

  2024cites this paper
• Innovative strategies for effective paclitaxel delivery: Recent developments and prospects

  2024cites this paper
• Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer

  2023cites this paper
• Targeting purine metabolism in ovarian cancer

  2022cites this paper
• Translational aspects of cytochrome P450‐mediated drug–drug interactions: A case study with clopidogrel

  2021cites this paper
• A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach

  2021cites this paper
• Drug metabolism and pharmacokinetic diversity of Taxus medicinal compounds

  2021cites this paper
• Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate

  2018influential citation
• Mrp3 Transports Clopidogrel Acyl Glucuronide from the Hepatocytes into Blood

  2018cites this paper
• Use of prescription drugs among women diagnosed with epithelial ovarian cancer in Denmark

  2018cites this paper
• Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review

  2017cites this paper
• Update on Chemotherapy-Induced Peripheral Neuropathy

  2017cites this paper
• Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters

  2017cites this paper
• Clopidogrel–Paclitaxel Drug–Drug Interaction: A Pharmacoepidemiologic Study

  2017cites this paper
• Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models

  2017cites this paper
• Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study

  2017cites this paper
• Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis

  2016cites this paper
• Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions

  2016cites this paper
• Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60-year-old Caucasian woman with ovarian carcinoma.

  2016cites this paper
• Potential drug interaction between paclitaxel and clopidogrel.

  2016cites this paper
• Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone

  2016cites this paper